MethodS:
A 2 year retrospective chart review of women who underwent the first-stage of two-stage immediate tissue expander reconstruction following skin-sparing mastectomy by two senior surgeons. Patients who had an inferior dermal flap were excluded. Patients were divided into two groups: Group 1 was reconstructed with ADM as an adjunct, and group 2 had a local adipofascial flap. Primary outcomes measures included intraoperative and first visit expander-fill volume, time to reach final fill volume, expansion ratios and clinic visits. Secondary outcome measures included the size of expander, pain during inpatient stay, and complications.
reSultS: 84 patients (148 expanders) were included: group 1 (ADM) had 41 patients (72 breasts) and group 2 (No ADM) had 43 patients (76 breasts). There were no statistical differences in patient demographics, mastectomy weight (P=0.10), and expander placement plane. There were no significant differences between the two groups of tissue expanders for intraoperative expansion volume (P=0.15), total expansion volume (P=0.28), and number of inflations required (P=0.18). Multivariate models adjusted for expander placement and postoperative radiation demonstrated that ADM patients had 0.13 higher expansion ratio intra-operatively (P=0.02) and at the first postoperative fill (P=0.001), but this did not differ significantly for final expansion volumes (P=0.58). There were 10 complications, 6 in the ADM and 4 in the no ADM groups. Complications were treated conservatively except two patients who had previous radiotherapy and requiring explantation for infection (ADM, N=1) and mastectomy skin flap necrosis (No ADM, N=1).
ConCluSion:
We provide an anatomical and simple surgical approach to successfully assess and perform adipofascial flaps for implant coverage. Autologous adipofascial tissue, if present, can provide reliable comparable coverage to the inferior pole of the implant with no increased morbidity, complications, and comparable outcomes and can have a beneficial cost reduction. Accurate estimations of the United States incidence and prevalence of BI-ALCL have been difficult to determine objeCtive: To determine the United States incidence and lifetime prevalence of BI-ALCL in women with textured breast implants.
referenCeS:
MethodS: This is a retrospective review of documented cases of BI-ALCL in the United States from 1996 to 2015.
The incidence and prevalence of BI-ALCL was determined based on textured breast prostheses sales figures from implant manufacturers' annualized data.
reSultS:
One-hundred pathologically confirmed BI-ALCL cases were identified in the United States from 1996-2015. Mean age was 53.2 ± 12.3 years. Interval from implant placement to diagnosis was 10.7 ± 4.6 years. Forty-nine patients had breast implants placed for cosmetic reasons, 44 for mastectomy reconstruction and 7 were unknown. Patients were diagnosed with BI-ALCL before 2000 (7%), from 2000-2013 (70%), or after 2013 (23%). Assuming BI-ALCL occurs only in textured breast implants, the incidence rate is 2.03 per 1,000,000 person-years (200 per 100 million), which is 70 times higher than that of breast ALCL (3 per 100 million) p<0.001. Lifetime prevalence was 33 per million persons with textured breast implants.
ConCluSionS:
Although women with a textured breast prosthesis have an exceedingly low risk of developing BI-ALCL, the current United States incidence is significantly higher than that of breast ALCL in the population. Further studies are required to determine if geographic, genetic, or surgical technique variability affects comparative susceptibility and disease risk.
